Atharva Karulkar - Dept Biosci & Bioengn, Indian Inst Technol

基本信息

Career Trajectory

Bio

No content for now

Research Interests

Papers共 24 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Implementation of a CAR-T Cell Therapy Program in India

Hema Hotchandani,Manju Sengar, Alok Shetty, Anupa John,Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Anjali Jaiswal, Yuktam Yadav, Sugandha Parkar, Anuradha Walawalkar, Sonali Kadam,Bhausaheb Bagal,Lingaraj Nayak,Rahul Purwar,Hasmukh Jain

Expert review of anticancer therapyno. 6 (2025): 599-608

Cited0Views0WOSBibtex

Correction: Novel Humanized CD19-CAR-T (now Talicabtagene Autoleucel, Tali-cel™) Cells in Relapsed/ Refractory Pediatric B-acute Lymphoblastic Leukemia- an Open-Label Single-Arm Phase-I/ib Study

Gaurav Narula, Swaminathan Keerthivasagam,Hasmukh Jain,Sachin Punatar,Akanksha Chichra,Chetan Dhamne,Prashant Tembhare,Papagudi Ganesan Subramanian,Nikhil Patkar,Minal Poojary,Anant Gokarn,Sumeet Mirgh,Nishant Jindal, Albeena Nisar, Deepali Pandit, Khushali Pandit,Alka Dwivedi,Atharva Karulkar, Ankesh Kumar Jaiswal,Aalia Khan, Shreshtha Shah,Afrin Rafiq, Moumita Basu,Juber Pendhari, Sweety Asija, Ambalika Chowdury, Ankit Banik,Nirmalya Roy Moulik,Shyam Srinivasan, Shilpushp Bhosle, Sumathi Hiregoudar, Shashank Ojha,Lingaraj Nayak,Jayshree Thorat,Bhausaheb Bagal,Manju Sengar,Navin Khattry,Shripad Banavali, Steven Highfill,Nirali N Shah,Rahul Purwar

Blood cancer journalno. 1 (2025): 98-98

Cited0Views0WOSNATUREBibtex

Talicabtagene Autoleucel for Relapsed or Refractory B-cell Malignancies: Results from an Open-Label, Multicentre, Phase 1/2 Study

Hasmukh Jain,Atharva Karulkar, Devanshi Kalra, Smrithi Ravikumar, Shreshtha Shah, Afrin Firfiray,Juber Pendhari, Ankesh Kumar Jaiswal,Aalia Khan, Manivasagam Sundharam, Anand Vaibhaw, Ashish Saroha, Shreewardhan Rajyopadhye, Moumita Basu, Sweety Asija, Ambalika Chowdhury, Rohit Beher, Ankit Banik,Alka Dwivedi, Shalini Purwar,Gaurav Narula,Shripad Banavali,Nitin Jain,Steven L Highfill,David Stroncek, Terry Fry, Sameer Melinkeri, Lovin Wilson, Narendra Agarwal, Anil Aribandi, Pavan Kumar Boyella,Nirali N Shah,Sattva S Neelapu,Manju Sengar,Rahul Purwar, CAR-T clinical trial group

The Lancet Haematology（2025）

Cited0Views0WOSBibtex

An Analysis of Infectious Complications Post-Treatment with Actalycabtagene Autoleucel

Hasmukh Jain, Rohan Verghese, Raveendra,Atharva Karulkar,Devanshi Kalra,Smrithi Ravikumar, Anjali Jaiswal,Shreshtha Shah,Afrin Firfiray,Neha Sharma,Thomas Eipe,Alok Shetty,Lingaraj Nayak,Bhausaheb Bagal,Manju Sengar,Rahul Purwar

Clinical Lymphoma Myeloma and Leukemia（2024）

Cited0Views0Bibtex

Talicabtagene Autoleucel (humanized CD19 CAR-T) As a Second Line Therapy in R/r B-Cell Lymphoma: Sub-Analysis from a Phase I/II Trial

Hasmukh Jain,Atharva Karulkar, Ankesh K. Jaiswal,Devanshi Kalra,Smrithi Ravikumar,Shreshtha Shah,Afrin Firfiray,Juber Pendhari,Neha Sharma,Alok Shetty,Lingaraj Nayak,Bhausaheb Bagal,Shripad Banavali,Gaurav Narula, Sameer Ramesh Melinkeri, Anil Aribandi,Narendra Agrawal, Lovin Wilson, Preeti Desai,Anisha Navkudkar,Prashant Tembhare,Navin Khattry,Epari Sridhar,Nikhil Patkar,Tanuja Shet,Uma Sakhadeo,Papagudi Ganesan Subramanian,Jayshree Thorat,Kinjalka Ghosh,Archi Agrawal,Yash Jain,Venkatesh Rangarajan, Shilpushp Bhosle,Siddhartha Laskar,Sangeeta Kakoti,Nitin Shetty,Vasundhara Patil,Akshay Baheti,Sanjay Biswas,Gaurav Salunkhe,Kunal Gala, Shalini Purwar,Manju Sengar,Nirali N. Shah,Sattva S. Neelapu,Rahul Purwar

Bloodno. Supplement 1 (2024): 7203-7203

Cited0Views0Bibtex

Real World Data of Novel Talicabtagene Autoleucel (humanized CD19 CAR-T) from India; Ensuring Equitable Access with Excellent Safety and Efficacy Profile

Hasmukh Jain,Atharva Karulkar,Devanshi Kalra,Smrithi Ravikumar,Shreshtha Shah,Afrin Firfiray,Juber Pendhari, Manivasagam S, Anand Vaibhaw, Ashish Saroha, Ankesh K. Jaiswal,Alok Shetty,Lingaraj Nayak,Bhausaheb Bagal, Neeraj Siddharthan,Esha Kaul,Prashant Mehta, Anshul Gupta,Navin Khattry,Nishant Jindal, Sanket P Shah, Rakesh Kumar Boya,Pavan Kumar Boyella, Preeti Desai,Anisha Navkudkar, Shalini Purwar,Manju Sengar,Nirali N. Shah,Sattva S. Neelapu,Rahul Purwar

Blood（2024）

Cited0Views0Bibtex

Development of a Novel Humanized BCMA-Directed CAR for Multiple Myeloma: Robust Activity and Low Toxicity in Preclinical Studies

Aalia N. Khan,Jayant S. Goda,Sweety Asija,Atharva Karulkar, Pranoti Palkar, Ambalika Chowdury, Ankesh K. Jaiswal, Deepti Phadnis,Shreshtha Shah,Afrin Firfiray,Juber Pendhari, Pranali Patil,Nirali N. Shah,Manju Sengar,Hasmukh Jain,Rahul Purwar

Bloodno. Supplement 1 (2024): 4809-4809

Cited0Views0Bibtex

Evaluating the Safety of HCAR19 (now Actalycabtagene Autoleucel- Actaly-Cel™), a Novel Humanized CD19-Directed Chimeric Antigen Receptor T-Cells in Pediatric, Adolescents, and Young Adults with Relapsed/ Refractory B- Acute Lymphoblastic Leukemia (ESHA) - Report of Phase-1B

BLOOD（2023）

Cited2Views0Bibtex

Supplementary Table 1 from the Th9 Axis Reduces the Oxidative Stress and Promotes the Survival of Malignant T Cells in Cutaneous T-Cell Lymphoma Patients

Sushant Kumar,Bhavuk Dhamija,Soumitra Marathe,Sarbari Ghosh,Alka Dwivedi,Atharva Karulkar,Neha Sharma,Manju Sengar, Epari Sridhar,Avinash Bonda,Jayashree Thorat,Prashant Tembhare,Tanuja Shet, Sumeet Gujral,Bhausaheb Bagal, Siddhartha Laskar,Hasmukh Jain,Rahul Purwar

openalex（2023）

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn